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 Mitochondrial DNA (mtDNA) encodes a subset of genes which are essential for 
oxidative phosphorylation. Deletions in the mtDNA can ablate a number of these genes, 
and result in mitochondrial dysfunction which is associated with bona-fide mitochondrial 
disorders. Although mtDNA deletions are thought to occur as a result of replication errors 
or following double-strand breaks, the exact mechanism(s) behind deletion formation 
have yet to be determined. In this review we discuss the current knowledge about the fate 
of mtDNA following double-strand breaks, including the molecular players which mediate 
the degradation of linear mtDNA fragments, and possible mechanisms of re-
circularization. We propose that mtDNA deletions formed from replication errors versus 
following double-strand breaks can be mediated by separate pathways.  
Mitochondrial DNA 
The human mitochondrial DNA (mtDNA) is a 16,569 bp circular, double-stranded, 
supercoiled molecule which was first discovered in 1963 [1]. The mtDNA molecule 
encodes 37 different genes which are essential for oxidative phosphorylation (OXPHOS) 
and mitochondrial protein synthesis [2]. Of these, 13 genes encode for subunits of 4 of 
the 5 multi-subunit enzymatic OXPHOS complexes located on the inner mitochondrial 
membrane: 7 subunits of Complex I, 1 subunit of Complex III, 3 subunits of Complex IV, 
and 2 subunits of Complex V. All of the subunits of Complex II are encoded by the nuclear 
DNA (nDNA), along with the other subunits and assembly factors needed for the 
biogenesis of the OXPHOS system [3]. Relative to its size, the lack of intron sequences, 
and the number of encoded genes, there is a high density of genetic information encoded 
by the mtDNA. To accommodate this density, some of the genes lack complete 
termination codons or overlap one another [4]. One interesting feature of the mammalian 
mtDNA molecule is there are two origins of replication, the origin of replication of the 
heavy (H-) strand (OH) and the origin of replication of the light (L-) strand (OL) [3]. 
Compared to the nuclear genome, where there are 2 copies of each chromosome, 
there can be 1000’s of copies of the mitochondrial genome per cell [5]. Due to its high 
copy number, wild-type and mutant mtDNA molecules can exist together in a single cell, 
a concept known as mitochondrial DNA heteroplasmy [6]. MtDNA heteroplasmy levels 
are dynamic since mtDNA replication is cell-cycle independent, and the mtDNA molecules 
selected for replication is random [7]. The type of mutation or deletion and the percentage 
of heteroplasmy are the major factors which determine the clinical severity of 
mitochondrial diseases. The percent heteroplasmy must surpass a biochemical threshold 
for decreased mitochondrial function and a clinical phenotype. While this threshold is 
dependent on the mutation itself, the affected cell- or tissue-type, heteroplasmy levels 
can be between 60 – 90% for a detectable phenotype to be present [8]. 
Mitochondrial DNA deletions are associated with disease 
Large deletions in the mtDNA are observed in patients with progressive external 
ophthalmoplegia (PEO), Kearns-Sayre syndrome (KSS) and Pearson’s syndrome [9-13]. 
They are invariably heteroplasmic and can vary in size from 1.8 – 8 kb [14, 15]. They can 
exist anywhere in the mtDNA, removing many protein coding and RNA genes , though 
there are some areas of the mtDNA that are much more susceptible to deletion formation 
than others [11, 16]. The molecular mechanisms underlying the formation of deleted 
mtDNA molecules remains unknown. It is known that the formation of deletions is usually 
sporadic, and they are generally thought not to be maternally transmitted [16]. Though a 
2004 study analyzing 226 families in which a single mtDNA deletion had been identified, 
the actual risk of transmission to the offspring was approximately 1 in 24 births [17]. If 
heteroplasmy is particularly high for a mtDNA deletion in multiple tissues in a young 
patient, the prevailing theory is that the deletion occurred early in development, shortly 
after the mtDNA bottleneck and clonally expanded to high heteroplasmy with the potential 
to affect many organs [17]. Accumulation of mtDNA deletions in post-mitotic tissues is 
also observed during normal aging [18-22]. It is likely that these deletions are formed by 
the same mechanisms as disease-associated ones, discussed below. 
Mitochondrial DNA replication 
MtDNA replication occurs independently of the cell cycle because mtDNA levels 
are generally dependent on the energy status of a cell. While the key proteins which 
mediate mtDNA replication have been described (including the mitochondrial DNA 
polymerase gamma (POLG), the mitochondrial DNA helicase (TWINKLE), the 
mitochondrial single-stranded binding protein (mtSSB), and the mitochondrial RNA 
polymerase (POLRMT)), the mechanisms of copy number regulation have remained 
elusive [7, 13, 23, 24]. Though three models for mtDNA replication have been proposed, 
the strand-displacement model (SDM) [25], the ribonucleotide incorporation throughout 
the lagging strand model (RITOLS) [26] and the strand-coupled model [27], the SDM 
model is more widely accepted (Figure 1) [28]. With the SDM mtDNA model replication 
occurs via continuous synthesis from both OH and OL. Replication is initiated at OH and a 
new H-strand is produced by POLG as DNA synthesis proceeds. As the mtDNA is 
unwound by TWINKLE, the displaced original heavy strand is coated with mtSSB, 
preventing POLRMT-initiated transcription. As POLG approaches OL, close to 2/3 of the 
mtDNA molecule has been replicated; when it passes OL, this single-stranded sequence 
folds into a stem-loop structure. This structure prevents mtSSB binding, and instead 
promotes POLRMT binding. POLRMT initiates primer synthesis for approximately 25 
nucleotides before it is replaced by POLG to begin L-strand synthesis. From this point on, 
both H-strand and L-strand synthesis continue out until the entire molecule has been 
replicated; replication is terminated at either OH or OL, dependent on where synthesis was 
initiated [24, 28-30]. 
Dual role of mitochondrial DNA replication machinery in degrading damaged 
mitochondrial DNA 
Mutations affecting the genes required for mtDNA replication can lead to the 
accumulation of mtDNA point mutations or large-scale rearrangements as well as mtDNA 
depletion [31]. In the clinic, mutations in POLG, TWINKLE, and the mitochondrial genome 
maintenance exonuclease 1 (MGME1) are associated with mtDNA instability disorders. 
Mutations in POLG are associated with diseases such as, progressive external 
ophthalmoplegia (PEO), Alpers-Huttenlocher syndrome, myoclonic epilepsy, myopathy 
sensory ataxia, and ataxia neuropathy spectrum disorders [24]. Patients with mutations 
in MGME1 suffer from PEO, skeletal muscle wasting/weakness, emaciation, respiratory 
distress, microcephalus, mental retardation and gastrointestinal symptoms [32, 33]. 
Patients with mutations in TWINKLE are also associated with PEO, spinocerebellar 
ataxia, and mtDNA depletion syndromes [34, 35].  
To better understand the roles of these genes in mtDNA instability and 
mutation/deletion formation, mouse models harboring specific mutations (POLG and 
TWINKLE) or knockout of the whole protein (MGME1) have been generated. In the mid-
2000’s two groups generated similar exonuclease-deficient Polg mouse models, which 
are referred to as the “mutator” mouse [36, 37]. The 3’ – 5’ exonuclease activity of POLG 
gives the polymerase its proofreading capability and the p.D257A point mutation in the 
murine POLG abolishes this activity. Mutator mice accumulate mtDNA point mutations 
and a linear 11 kb fragment, as well as low levels of deletions occurring between OH and 
OL, knowns as major arc deletions, in different tissues. Interestingly, when studying the 
mtDNA point mutation and deletion load in the mutator mouse, the incidence of deletions 
correlates well with the premature aging phenotype [38, 39]. Later studies showed that 
point mutations in mtDNA-encoded protein coding genes also correlated well with the 
phenotype [40]. A TWINKLE mouse model was made with p.A360T substitution or an in 
frame amino acid duplication at position 353-365, which are seen in patients with PEO 
[41].These mutant Twinkle mice are known as the “deletor” mice as they have multiple 
mtDNA deletions, along with progressive respiratory dysfunction and late-onset 
mitochondrial disease. The multiple deletions seen in the deletor mouse have been 
attributed to replication pausing or stalling, which can also lead to mtDNA depletion, as it 
is seen in PEO patients [34, 42]. A full body MGME1 knockout mouse was recently 
generated which also generates mtDNA depletion, duplications, and multiple deletions 
across many different tissues types commonly seen in patients with PEO [33, 43]. 
Analysis of the mtDNA point mutation load in the livers of young and aged MGME1 
knockouts revealed low levels of mtDNA point mutations, similar to levels observed in 
wild-type mice. Similar to the mutator mice, the MGME1 knockout mice accumulate a 
linear 11 kb mtDNA fragment which corresponds to the major arc of the mtDNA (the 
longer fragment between OH and OL). However, unlike the mutator mice, the MGME1 
knockouts do not age prematurely, suggesting that increased mtDNA point mutation load, 
not deletion load, leads to the premature aging phenotype. 
Damage to the mtDNA can result in either the loss of the damaged mtDNA 
molecule or the formation of point mutations or rearrangements/deletions. This damage 
is either from errors in replication or noxious stimuli. Recent data suggests double-strand 
breask (DSBs) are central to one of the proposed mechanisms for the formation of mtDNA 
deletions; another mechanism is through slipped mtDNA replication, which will be 
discussed later in this review. 
DSBs can occur in the mtDNA via exposure to exogenous DNA damaging agents 
such as ionizing radiation, UV, and chemotherapeutic agents or endogenous agents, 
such as reactive oxygen species (ROS) [44, 45]. Oxidative damage may be particularly 
prevalent due to the close proximity of ROS–producing OXPHOS and the mtDNA, which 
may also promote other types of damage through base modifications and replication 
errors [44, 45]. The multicopy nature of mtDNA means that when a mtDNA molecule is 
damaged through DSBs, the damaged molecule is likely to be degraded and healthy 
molecules will replicate to restore mtDNA copy number rather than expend energy to 
repair the damaged molecule. Until recently the nucleases which degraded the linear 
mtDNA fragments were unknown. In addition to POLG and MGME1 there are other 
nucleases which have roles in the mitochondria including EXOG, APEX2, ENDOG, FEN1, 
DNA2, MRE11, and RBBP8 [46-48]. It has shown that mtDNA degradation following a 
DSB is a fast process, as a linear mtDNA intermediate is only seen for approximately 2 
hours after DSB induction, but not at later time points implying that mtDNA degradation 
occurs soon after DSBs [49]. 
In an in vitro model of mitochondrial–targeted restriction endonuclease (mitoRE) 
PstI (mitoPstI) induced DSBs a study tested whether knocking down MGME1, DNA2, 
EXOG, ENDOG, or FEN1 had an effect on the degradation of linear mtDNA fragments 
[50]. Using siRNAs to silence each of the nucleases independently and in a pool, the 
authors did not observe a delay in the degradation of linear mtDNA fragments following 
mitoPstI-induced DSBs at 0 hours, 5 hours, or 1 day [50]. A similar study was carried out 
by another group, using a comparable in vitro system to express mitoPstI after knocking 
down MGME1, POLG, TWINKLE, EXOG, APEX2, ENDOG, FEN1, DNA2, MRE11, and 
RBBP8. In contrast to the former study which was unable to attribute any role for MGME1 
in degrading linear mtDNA fragments following DSBs, the latter study observed delayed 
mtDNA degradation (via a linear mtDNA intermediate) 4 hours after the induction of 
mitoPstI in the MGME1-downregulated cell as well as in the POLG and TWINKLE 
knockdowns, but not the other nucleases [51]. To further characterize the exonuclease 
activity responsible for this delayed degradation, mitoEagI was expressed in HEK293 
cells which are either deficient for MGME1 or which harbor the human POLG p.D274A 
point mutation (abolishing the 3’–5’ exonuclease activity). In both cases delayed 
degradation was seen up to 18 hours after mitoEagI expression [51].  
Another independent study observed a similar role for the exonuclease activity of 
the mouse POLG in the degradation of linear mtDNA fragments both in vitro and in vivo 
using adenoviral mediated expression of mitoScaI (Ad-mitoScaI) in the mutator model 
[52]. Ad-mitoScaI had a peak of expression in lung-derived fibroblasts from mutator and 
wild-type mice one to two days after infection, but by days five and 10, expression was 
lost. Linear mtDNA fragments were observed in a southern blot at Day 1, but only the full 
length mtDNA molecule was observed at Days 5 and 10 in the mutator fibroblasts, 
implying that the exonuclease activity of POLG plays an early role in degrading linear 
mtDNA fragments, but it is not the only nuclease which can degrade these fragments. 
When Ad-mitoScaI was injected retro-orbitally in wild-type and mutator mice, a similar 
phenomenon was observed in the liver. Along with a general depletion of mtDNA, linear 
mtDNA fragments were also observed four days after Ad-mitoScaI infection in DNA 
extracted from the liver of the mutator mouse, compared to the liver of the Ad-mitoScaI 
injected wild-type mouse [52].  
In addition to its function in degrading linear mtDNA fragments following DSBs, 
POLG appears to have evolved to have many roles in regulating mtDNA stability. 
Recent work done has shown that MIP1, the yeast homolog of POLG, controls mtDNA 
copy number by regulating mtDNA synthesis and degradation in starving yeast cells 
which were deficient in Atg7 (DAtg7) [53]. Atg7 is a conserved component of the ubiquitin-
like system required for autophagy in yeast [54]. Additionally, they found that the 3’ – 
5’exonuclease activity of MIP1 regulated mtDNA copy number in wild-type yeast, as well 
as mediated the degradation of mtDNA in DAtg7 yeast during starvation-induced 
nucleotide insufficiency [53]. MtDNA deletion levels were analyzed in yeast MIP1 models 
of disease associated POLG mutations and an increase in mtDNA deletions was only 
seen in exonuclease-deficient MIP1 compared to wild-type or other pathogenic mutations 
[55].  
Formation of mitochondrial DNA deletions following double-strand breaks  
In a mouse model expressing the mitochondrially-targeted restriction 
endonuclease, mitoPstI (which has two recognition sites in the mouse mtDNA), in 
forebrain neurons showed the depletion of the full length mtDNA molecule [56]. However, 
recombination events were identified that occurred either between 1) the free ends 
generated by PstI cleaving the mtDNA at both sites (resulting in an approximately 12 kb 
mtDNA molecule) or 2) one of the free ends generated by PstI and a region close the D-
loop (resulting in an approximately 8 kb mtDNA molecule) [56-58]. The possibility of 
“repair” occurring between the two free ends could be explained by the recombinogenic 
features of these DNA ends. However, the break-points detected for a PstI end and the 
D-loop have been proposed to occur due to the relaxed three-stand confirmation of the 
D-loop, allowing for single strand annealing and recombination to occur [59]. 
 In the recent studies described above that showed roles for POLG, MGME1, and 
TWINKLE in degrading linear mtDNA following DSBs, both showed that a consequence 
of the persisting linear mtDNA fragments is the increased formation of mtDNA 
rearrangements. PCR analysis across the mitoPstI breakpoint showed an increase in the 
presence of a recombined molecule in the POLG, MGME1, and TWINKLE knockdown 
samples compared to controls at 2 and 4 hours after mitoPstI induction [51]. Another 
study analyzed the formation of three different putative mtDNA rearrangements which 
could have formed following Ad-mitoScaI, one which contained only OH, one which 
contained only OL, and one which contained both OH and OL [52]. Fibroblasts derived 
from the mutator mouse showed higher levels of all three putative recombined molecules 
at Days 1 and 2 after Ad-mitoScaI infection, however the levels of the molecules which 
contained only OH or only OL were reduced by Days 5 and 10. On the other hand, 
recombined molecules which contained both OH and OL were able to replicate and levels 
continued to increase through Day 10. These breakpoints were also analyzed in the livers 
of the mice retro-orbitally injected with Ad-mitoScaI and the levels of the OH and OL 
containing rearrangements were higher than those containing only a single origin of 
replication. 
Features of mitochondrial DNA deletion breakpoints are potential indicators of the 
mechanism of deletion formation 
As previously discussed, mammalian mtDNA molecules containing DSBs are 
usually rapidly eliminated, with the components of the replication machinery, including 
POLG, MGME1, and TWINKLE being involved in this process. However, evidence exist 
that in some instances DSB can be re-ligated resulting in a rearranged molecule [56]. 
While it was previously thought that DSB repair mechanisms do not exist in the 
mitochondria, the presence of rearranged molecules upon induction of DSB suggests that 
an end-joining activity actually operates within the mammalian mitochondria. This repair 
mechanism, however, is likely to be different from the precise mechanisms operating in 
the nucleus, because of the absence of specific bona-fide DSB repair factors, such as 
Rad51, Nbs1, members of the MRN complex [60-63]. Nonetheless, the observation that 
the free ends come together indicates a rudimentary DSB repair mechanism, resulting in 
the formation of partially-deleted mtDNA.  
Whereas mtDNA deletions that appear to arise from slipped replication are usually 
flanked by direct repeats, analysis of the mtDNA repair breakpoints after a DSB did not 
reveal the same features (Figure 2B). Instead there is evidence suggesting repair is 
mediated mostly by non-homologous end joining (NHEJ), or micro-homolog mediated end 
joining (MMEJ) [48, 56, 58, 64-66]. 
In Saccharomyces cerevisiae mtDNA DSBs are repaired by homologous 
recombination (HR) and the proteins which facilitate this repair in yeast have been 
previously identified [67, 68]. However, a number of factors of yeast mtDNA HR that do 
not have identified counterparts in the mammalian system, including the Rad52-like 
protein or a resolvase, while the other factors have known homologs (reviewed in [60]). 
There is a report that one of the factors of nDNA HR, Ku80, has an alternate form, 
XRCC1, which is found in mammalian mitochondria [62].  
The observation that deletion breakpoints seen in the human mtDNA across 
different mitochondrial diseases can have large, micro or no homologies, is consistent 
with some mechanism of NHEJ existing in the mitochondria [3]. These breakpoints would 
be formed purely through ligation of the free ends, and not show any sequence homology 
on either side of the break. This has been observed in the analysis of breakpoints between 
either two free mtDNA ends introduced by mitoRE or a free, mitoRE-specific mtDNA end 
and the displacement loop (D-loop), showing that these breakpoints are not flanked by 
any homologous sequences [56, 58].  
A more recent study found that classical NHEJ is unlikely to occur in the 
mitochondria following DSBs. Using an in vitro system, the authors incubated either cell 
free extracts or mitochondrial extracts isolated from different tissues (brain, testes, 
spleen, and kidney) from rats with [g-32P]ATP labeled double-stranded oligomeric DNA 
[48]. These oligonucleotides had either compatible 5’ overhangs, non-compatible 5’-5’ 
overhangs, non-compatible 3’-3’ overhangs or blunt ends which mimicked endogenous 
DSBs. While total cell extracts from all tissues were able to catalyze the formation of 
dimers, trimers, and other multimers with all types of overhangs by NHEJ, there was only 
evidence of the compatible 5’ overhangs ligating in the mitochondrial extracts from testes 
[48]. This type of joining does not require any type of processing before ligation, so while 
it does not rule out the possibility, it suggests that classical NHEJ does not occur in 
mitochondria. 
MMEJ is an alternative NHEJ pathways that was has also been explored. MMEJ 
was first thought to have a central role in mtDNA maintenance and repair following DSBs 
in 2008, when it was found that approximately 90% of mtDNA deletions in human cells 
were flanked by short, direct or imperfect repeat sequences [64, 69]. Using a similar in 
vitro system, double-stranded DNA oligos harboring 13 nucleotide direct repeats were 
incubated independently with mitochondrial or cell free extracts, PCR amplified, post-
digested, and resolved by polyacrylamide gel electrophoresis. The authors found the 
presence of a larger fragment which would be expected from the MMEJ Sequence 
analyses of the breakpoints showed 68% of perfect microhomologies, while 32% showed 
imperfect microhomologies with up to 2 mismatches [48]. In summary, the mechanism by 
which DSB lead to mtDNA deletion formation is unclear and could be as simple as ligase 
3-mediated ligation. 
The features of deletion breakpoints after DSBs showed a paucity of homology in 
the regions involved in the breakpoint, occurring at or close to the cleavage site, 
suggesting limited degradation of the free ends [52]. These features contrast with 
observations in most patients with mtDNA deletions, where nearly 60% of deletions are 
flanked by short, directly repeated sequences between 4 – 13 bp, known as Class I 
deletions [64, 70-78]. Thirty percent of patient-derived deletions are flanked by imperfect 
repeat sequences, known as Class II deletions, and the remaining deletions, are flanked 
by non-repetitive sequences, known as Class III deletions [69]. Most clinically observed 
deletions are located between the two origins of replication when the H-strand is 
displaced, suggesting replication intermediates mediate deletion formation. This is 
consistent with the SDM of mtDNA replication. Over the years, different models for the 
formation of these mtDNA deletions have been proposed. One such model, the slipped-
strand replication model, has been proposed to explain the formation of the common 
deletion, a 4,977 bp deletion found in the major arc that is one of the most common 
mtDNA mutations [11, 76]. One of these studies suggested that during the displacement 
of the nascent H-strand, a repeat sequence on the H-strand anneals with a homologous 
sequence on the L-strand, creating a wild-type mtDNA molecule and a deleted mtDNA 
molecule [11]. Later work suggested that the activity required for mtDNA strand annealing 
are mediated by members of the minimal mitochondrial replisome and is coupled to 
mtDNA replication [79]. Furthermore, in a more recent model, named “copy-choice 
recombination”, experimental data suggested that mtDNA deletions can be formed via 
slipped replication during the synthesis of the nascent L-strand. According to this model, 
the 3′ end of the nascent L-strand is displaced from the template H-strand soon after 
passing one of the sequences of a tandem repeat and can reanneal to the second 
repeated sequence on the template H-strand. This 3′-end slippage would lead to a mtDNA 
deletion upon a subsequent replication round (Figure 2A) [80]. 
Concluding remarks and future perspectives 
 A hallmark feature of mtDNA is the ability to quickly recover from a rapid loss of 
mtDNA molecules following DSBs both in vitro and in vivo. Up until recently the nucleases 
which degrade linear mtDNA fragments following DSBs had not been determined, but 
now we know that members of the mtDNA replication machinery play dual roles in 
synthesizing and degrading mtDNA, and these roles are likely independent of one 
another. If linear mtDNA molecules are not rapidly degraded following DSBs there is the 
increased likelihood of the formation of mtDNA deletions, either between the free ends 
generated by the DSB or between a free end and a region close to the D-loop. Therefore, 
DSB is at least one of the mechanisms by which mtDNA deletions can be formed. It is 
likely that mtDNA deletions without homologies in the breakpoint may be formed after 
DSBs. On the other hand, replication errors are also likely to generate mtDNA deletions, 
and these would be mediated by some homology at the breakpoint region (Figure 2). 
Presently, gene therapy tools, such as mitoTALENs and mtZFNs, have been utilized to 
specifically create DSBs to cleave mtDNA to effectively shift mtDNA heteroplasmy both 
in vitro and in vivo [81-84]. The off-target effects of these DSBs, including the formation 
of mtDNA deletions, is a concern with moving these techniques into the clinical setting. 
However, recent work has shown that functionally relevant levels of mtDNA deletions form 
only when there are mutations in the mtDNA replication machinery, opening the door to 
move these tools forward. 
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Figure 1. Strand-displacement model of mitochondrial DNA replication. 
Schematic representation of mitochondrial DNA replication through the strand 
displacement model. Mitochondrial DNA replication is initiated at OH and proceeds 
unidirectionally to produce the nascent H-strand. When replication of the H-strand passes 
OL, replication of the nascent L-strand is initiated. Continuous synthesis of the nascent H- 
and L-strands proceeds until two full-length, double-stranded mtDNA molecules have 
been formed.  
 
Figure 2. Mitochondrial DNA deletions have two origins of formation.  
Deletions in mtDNA can form by copy-choice recombination mtDNA replication or after a 
double-strand break. (A) During copy-choice recombination, which assumes the strand-
displacement model of replication, mtDNA replication begins at OH, and proceeds to OL 
where synthesis of the nascent L-strand begins. As the repeat closest to OL, marked as 
the 3’ repeat, is displaced from the template H-strand, it can reanneal to the repeat closest 
to OH, marked as the 5’ repeat, on the template H-strand. After the first round of 
replication, there would be a complete wild-type mtDNA molecule, and a mtDNA molecule 
harboring both a wild-type mtDNA strand and a deletion strand. A subsequent round of 
replication leads to a wild-type mtDNA molecule and a deleted mtDNA (DmtDNA) 
molecule, where the breakpoint is flanked by direct or imperfect repeats. (B) Following a 
double strand break, the mtDNA is either rapidly degraded by members of the mtDNA 
replication machinery (including as POLG, MGME1, and TWINKLE) or only partially 
degraded, where the free ends are able to ligate and a DmtDNA molecule can form. This 
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